Canada Life’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Sell
59,514
-3,995
-6% -$86.1K ﹤0.01% 1273
2025
Q4
$1.27M Buy
63,509
+11,931
+23% +$233K ﹤0.01% 1320
2025
Q3
$982K Buy
51,578
+3,774
+8% +$73.6K ﹤0.01% 1448
2025
Q2
$961K Sell
47,804
-15,895
-25% -$306K ﹤0.01% 1447
2025
Q1
$1.15M Sell
63,699
-6,095
-9% -$109K ﹤0.01% 1390
2024
Q4
$1.21M Buy
69,794
+10,993
+19% +$211K ﹤0.01% 1423
2024
Q3
$1.13M Hold
58,801
﹤0.01% 1482
2024
Q2
$964K Buy
58,801
+9,241
+19% +$143K ﹤0.01% 1514
2024
Q1
$755K Buy
49,560
+2,242
+5% +$35.2K ﹤0.01% 1572
2023
Q4
$757K Sell
47,318
-4,520
-9% -$63.2K ﹤0.01% 1586
2023
Q3
$674K Sell
51,838
-1,195
-2% -$15.5K ﹤0.01% 1602
2023
Q2
$675K Sell
53,033
-6,727
-11% -$84.2K ﹤0.01% 1608
2023
Q1
$672K Hold
59,760
﹤0.01% 1617
2022
Q4
$791K Sell
59,760
-9,044
-13% -$119K ﹤0.01% 1589
2022
Q3
$799K Buy
68,804
+8,585
+14% +$118K ﹤0.01% 1567
2022
Q2
$888K Buy
60,219
+6,990
+13% +$115K ﹤0.01% 1509
2022
Q1
$1.06M Hold
53,229
﹤0.01% 1510
2021
Q4
$918K Hold
53,229
﹤0.01% 1550
2021
Q3
$897K Hold
53,229
﹤0.01% 1559
2021
Q2
$713K Sell
53,229
-1,986
-4% -$24.9K ﹤0.01% 1642
2021
Q1
$659K Sell
55,215
-7,066
-11% -$85.4K ﹤0.01% 1676
2020
Q4
$771K Sell
62,281
-13,062
-17% -$141K ﹤0.01% 1614
2020
Q3
$788K Sell
75,343
-7,258
-9% -$92.2K ﹤0.01% 1504
2020
Q2
$1.16M Sell
82,601
-6,603
-7% -$89.8K ﹤0.01% 1362
2020
Q1
$1.05M Buy
89,204
+5,644
+7% +$74.6K ﹤0.01% 1269
2019
Q4
$1.17M Buy
+83,560
New +$1.03M ﹤0.01% 1418
2019
Q3
Sell
-90,814
Closed -$1.32M 1683
2019
Q2
$1.32M Hold
90,814
﹤0.01% 1398
2019
Q1
$1.27M Hold
90,814
﹤0.01% 1293
2018
Q4
$1.46M Buy
90,814
+3,099
+4% +$50.3K ﹤0.01% 1215
2018
Q3
$1.34M Hold
87,715
﹤0.01% 1400
2018
Q2
$1.21M Hold
87,715
﹤0.01% 1456
2018
Q1
$1.46M Sell
87,715
-7,455
-8% -$115K ﹤0.01% 1335
2017
Q4
$1.35M Sell
95,170
-3,900
-4% -$52K ﹤0.01% 1399
2017
Q3
$1.38M Sell
99,070
-12,180
-11% -$161K ﹤0.01% 1387
2017
Q2
$1.42M Buy
111,250
+3,940
+4% +$49.4K ﹤0.01% 1355
2017
Q1
$1.48M Buy
107,310
+7,475
+7% +$88K ﹤0.01% 1298
2016
Q4
$1.07M Buy
99,835
+86,045
+624% +$903K ﹤0.01% 1458
2016
Q3
$151K Hold
13,790
﹤0.01% 1989
2016
Q2
$145K Hold
13,790
﹤0.01% 1968
2016
Q1
$173K Buy
13,790
+7,415
+116% +$81.4K ﹤0.01% 1402
2015
Q4
$67K Hold
6,375
﹤0.01% 2016
2015
Q3
$46K Hold
6,375
﹤0.01% 2108
2015
Q2
$115K Hold
6,375
﹤0.01% 1756
2015
Q1
$100K Sell
6,375
-1,450
-19% -$21.9K ﹤0.01% 1795
2014
Q4
$108K Buy
7,825
+1,450
+23% +$21.8K ﹤0.01% 1693
2014
Q3
$109K Hold
6,375
﹤0.01% 1614
2014
Q2
$189K Buy
6,375
+1,634
+34% +$39.2K ﹤0.01% 1167
2014
Q1
$117K Hold
4,741
﹤0.01% 1357
2013
Q4
$137K Buy
+4,741
New +$139K ﹤0.01% 1261

Other funds holding INVA

Canada Life's INVA Position: Q1 2026 in Review

Canada Life reduced its Innoviva (INVA) stake by 6.3% in Q1 2026, selling an estimated $86.1K and leaving 59,514 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Canada Life first reported a position in INVA in Q4 2013 and has held it in 49 quarters since. The position peaked at $1.48M in Q1 2017. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Canada Life held 59,514 shares of Innoviva worth $1.39M as of Q1 2026.
  • Canada Life sold 3,995 Innoviva shares in Q1 2026, an estimated $86.1K.
  • Innoviva made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1273 holding.
  • Canada Life first reported a position in Innoviva in Q4 2013 and has held it in 49 quarters since.
  • Canada Life's Innoviva position peaked at $1.48M in Q1 2017.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.